Diagnostic and Biotech

Metagenomics Market to 2027 - Global Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Geography

  • THE3206922
  • 139 Pages
  • January 2019
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The global metagenomics market is expected to reach US$ 314.3 Mn in 2027 from US$ 165.8 in 2018. The market is estimated to grow with a CAGR of 7.7% from 2018-2027.

Driving factors such as increasing venture capital investments, advantages of metagenomics in biotechnology and industrial applications of metagenomics. Whereas, the trend of the extensive set of molecular-based approaches positive impact on the growth of the market in the coming years. However, high capital costs of metagenomics is anticipated to restrain the market growth. The extensive research for the microbial studies are being conducted to study the genetic make-up of the microorganisms. The collection of the microbial sample collected from the environmental resources owes the huge diversity in their genes. The study have helped to discover antibiotics and are expected to assist more in the drug discovery in the coming future. The current trend of the molecular-based approaches has enabled the field of the metagenomics to study the uncultured microorganisms. The metagenomics has also helped in the huge way for the clinical diagnostics and the clinical diagnostics is the current trend going on cross the world. Also the extensive research is been going-on currently for the environmental sectors. Also the metagenomics have potential to discover products for the biotechnology, agriculture biotechnology, food technology and others. The potential of the metagenomics in the pharmaceuticals owe to the large hopes for growth opportunities for the market players. Also the novel innovations from the market players are likely to discover the solutions for the chronic infectious diseases. The initial cost of the primary set up for the metagenomics is very high, however, the technological advancement and the efforts by the market leader such as Illumina Inc., Pacific Bioscience of California Inc., among the others are likely to meet this challenge. These market players are aggressively working to provide cost effective solutions for the metagenomics studies. The healthcare industry is likely to experience the positive outcomes in the coming future.

Global metagenomics market, based on the application was segmented into clinical diagnostics, drug discovery, and other applications. Clinical Diagnostics segment is anticipated to grow at a CAGR of 7.2% during the forecast period. The metagenomics offers prodigious potential for the identification of uncultured microorganism that can be used to detect and diagnose infectious diseases and the genetic properties of the microorganism. Therefore, the segment held the largest market share of 47.9% for the application segment in the metagenomics market and is likely to dominate the market in coming forecast period.

Some of the major primary and secondary sources included in the report for the metagenomics market are Brazilian Microbiome Project, Centers for Disease Control and Prevention, Canada and Canadian Institutes of Health Research Institute of Infection and Immunity, Council of Scientific & Industrial Research, Department of Biotechnology, International Center for Biosaline Agriculture, Janssen Human Microbiome Institute, Joint Genome Institute, and others.

TABLE OF CONTENTS

1. INTRODUCTION

1.1 SCOPE OF THE STUDY

1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. GLOBAL METAGENOMICS MARKET - KEY TAKEAWAYS

3. GLOBAL METAGENOMICS MARKET - MARKET LANDSCAPE

3.1 OVERVIEW

3.2 MARKET SEGMENTATION

3.2.1 Global Metagenomics Market - By Product

3.2.2 Global Metagenomics Market - By Application

3.2.3 Global Metagenomics Market - By Geography

3.3 PEST ANALYSIS

3.3.1 North America - PEST Analysis

3.3.2 Europe- PEST Analysis

3.3.3 Asia Pacific- PEST Analysis

3.3.4 Middle East And Africa- PEST Analysis

3.3.5 South and Central America - PEST Analysis

4. GLOBAL METAGENOMICS MARKET - KEY MARKET DYNAMICS

4.1 KEY MARKET DRIVERS

4.1.1 Increasing Venture Capital Investments

4.1.2 Advantages of Metagenomics in Biotechnology

4.1.3 Industrial Applications of Metagenomics

4.2 KEY MARKET RESTRAINTS

4.2.1 High Capital Costs Of Metagenomics

4.3 KEY MARKET OPPORTUNITIES

4.3.1 Usage of Metagenomics for Precision Medicine

4.3.2 Emerging Nations

4.4 KEY MARKET TRENDS

4.4.1 Extensive Set Of Molecular-Based Approaches

4.5 IMPACT ANALYSIS

5. METAGENOMICS MARKET - GLOBAL ANALYSIS

5.1 GLOBAL METAGENOMICS MARKET REVENUE FORECASTS AND ANALYSIS

5.2 GLOBAL METAGENOMICS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS

5.3 MARKET POSITIONING

5.4 PERFORMANCE OF KEY PLAYERS

5.4.1 Illumina, Inc.

5.4.2 Qiagen

5.5 EXPERT OPINIONS

6. GLOBAL METAGENOMICS MARKET ANALYSIS - BY PRODUCT

6.1 OVERVIEW

6.2 GLOBAL METAGENOMICS MARKET, BY PRODUCT, 2018 & 2027 (%)

6.3 INSTRUMENTS & SOFTWARE MARKET

6.3.1 Overview

6.3.2 Global Instruments & Software Market Revenue and Forecasts to 2027 (US$ Mn)

6.4 CONSUMABLES MARKET

6.4.1 Overview

6.4.2 Global Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

7. GLOBAL METAGENOMICS MARKET ANALYSIS - BY APPLICATION

7.1 OVERVIEW

7.2 GLOBAL METAGENOMICS MARKET, BY APPLICATION, 2018 & 2027 (%)

7.3 CLINICAL DIAGNOSTIC MARKET

7.3.1 Overview

7.3.2 Global Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)

7.4 DRUG DISCOVERY METAGENOMICS MARKET

7.4.1 Overview

7.4.2 Global Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

7.5 OTHERS MARKET

7.5.1 Overview

7.5.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027

8.1 OVERVIEW

8.2 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.3 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

8.4 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)

8.5 NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)

8.6 US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.6.1 US Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.6.2 US Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.6.3 US Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

8.7 CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.7.1 Canada Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.7.2 Canada Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.7.3 Canada Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

8.8 MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.8.1 Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.8.2 Mexico Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.8.3 Mexico Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027

9.1 OVERVIEW

9.2 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

9.3 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

9.4 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)

9.5 EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)

9.6 UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

9.6.1 UK Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.2 UK Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.6.3 UK Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.7 GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

9.7.1 Germany Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

9.7.2 Germany Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.7.3 Germany Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.8 FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

9.8.1 France Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

9.8.2 France Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.8.3 France Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027

10.1 OVERVIEW

10.2 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

10.3 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

10.4 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)

10.5 ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)

10.6 CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

10.6.1 China Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

10.6.2 China Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.6.3 China Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.7 JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

10.7.1 Japan Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

10.7.2 Japan Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.7.3 Japan Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

10.8 INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

10.8.1 India Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

10.8.2 India Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.8.3 India Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

11. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027

11.1 OVERVIEW

11.2 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

11.3 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

11.4 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)

11.5 MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)

11.6 UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

11.6.1 UAE Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

11.6.2 UAE Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.6.3 UAE Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.7 SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

11.7.1 Saudi Arabia Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

11.7.2 Saudi Arabia Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.7.3 Saudi Arabia Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.8 SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

11.8.1 South Africa Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

11.8.2 South Africa Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

11.8.3 South Africa Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

12. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027

12.1 OVERVIEW

12.2 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

12.3 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

12.4 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN)

12.5 SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)

12.6 BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

12.6.1 Brazil Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

12.6.2 Brazil Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

12.6.3 Brazil Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

13. METAGENOMICS MARKET -INDUSTRY LANDSCAPE

13.1 OVERVIEW

13.2 GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018

13.3 ORGANIC DEVELOPMENTS

13.3.1 Overview

13.4 ORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018

13.5 PRODUCT LAUNCH

13.5.1 Recent Product Launch By Players In The Metagenomics Market

13.6 PRODUCT APPROVAL

13.6.1 Recent Product Approval By Players In The Metagenomics Market

13.7 EXPANSION & OTHERS

13.7.1 The Metagenomics Market By Expansion & Other Growth Strategies

13.8 INORGANIC DEVELOPMENTS

13.8.1 Overview

13.9 INORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018

13.10 ACQUISITIONS

13.10.1 Acquisitions By Players In The Metagenomics Market

13.11 AGREEMENTS

13.11.1 The Metagenomics Market By Agreements

13.12 PARTNERSHIP & COLLABORATION

13.12.1 Partnership By Players In The Metagenomics Market

14. METAGENOMICS MARKET-KEY COMPANY PROFILES

14.1 MERCK KGAA

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Financial Overview

14.1.4 Product Portfolio

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 THERMO FISHER SCIENTIFIC, INC.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Financial Information

14.2.4 Product Portfolio

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 AGILENT TECHNOLOGIES, INC.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Financial Overview

14.3.4 Product Portfolio

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 QIAGEN

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Financial Overview

14.4.4 Product Portfolio

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 BIO-RAD LABORATORIES, INC.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Financial Information

14.5.4 Product Portfolio

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 PERKIN ELMER, INC.

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Financial Overview

14.6.4 Product Portfolio

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 ILLUMINA, INC.

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Financial Overview

14.7.4 Product Portfolio

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 F. HOFFMANN-LA ROCHE LTD.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Financial Overview

14.8.4 Product Portfolio

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 OXFORD NANOPORE TECHNOLOGIES LTD.

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Financial Overview

14.9.4 Product & Services Portfolio

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 PACIFIC BIOSCIENCE OF CALIFORNIA, INC.

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Financial Overview

14.10.4 Product & Services Portfolio

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. APPENDIX

15.1 ABOUT THE INSIGHT PARTNERS

15.2 GLOSSARY OF TERMS

15.3 METHODOLOGY

15.3.1 Coverage

15.3.2 Secondary Research

15.3.3 Primary Research

LIST OF TABLES

TABLE 1. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 2. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 3. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

TABLE 4. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 5. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

TABLE 6. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 7. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

TABLE 8. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 9. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 10. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 11. UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

TABLE 12. UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 13. GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

TABLE 14. GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 15. FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

TABLE 16. FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 17. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 18. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 19. CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

TABLE 20. CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 21. JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

TABLE 22. JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 23. INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

TABLE 24. INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 25. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 26. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 27. UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

TABLE 28. UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 29. SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

TABLE 30. SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 31. SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

TABLE 32. SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 33. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 34. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 35. BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT (US$ MN)

TABLE 36. BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 37. RECENT PRODUCT LAUNCH IN THE METAGENOMICS MARKET

TABLE 38. RECENT PRODUCT APPROVAL AND ENHANCEMENTS IN THE METAGENOMICS MARKET

TABLE 39. THE METAGENOMICS MARKET BY EXANSION & OTHERS STRATEGIES

TABLE 40. ACQUISITIONS IN THE METAGENOMICS MARKET

TABLE 41. THE METAGENOMICS MARKET BY AGREEMENTS

TABLE 42. PARTNERSHIP IN THE METAGENOMICS MARKET

TABLE 43. GLOSSARY OF TERMS, METAGENOMICS MARKET

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC METAGENOMICS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2027

FIGURE 2. GLOBAL METAGENOMICS MARKET BY PRODUCT, MARKET SHARE (%), 2018

FIGURE 3. GLOBAL METAGENOMICS MARKET BY APPLICATION, MARKET SHARE (%), 2018

FIGURE 4. METAGENOMICS MARKET SEGMENTATION

FIGURE 5. METAGENOMICS SEGMENTATION, BY REGION

FIGURE 6. NORTH AMERICA PEST ANALYSIS

FIGURE 7. EUROPE PEST ANALYSIS

FIGURE 8. ASIA PACIFIC PEST ANALYSIS

FIGURE 9. MIDDLE EAST AND AFRICA PEST ANALYSIS

FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS

FIGURE 11. METAGENOMICS MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS

FIGURE 12. GLOBAL METAGENOMICS MARKET - REVENUE FORECASTS AND ANALYSIS - 2018- 2027

FIGURE 13. GLOBAL METAGENOMICS MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2018- 2027

FIGURE 14. GLOBAL METAGENOMICS MARKET BY PRODUCT, 2018 & 2027 (%)

FIGURE 15. GLOBAL INSTRUMENTS & SOFTWARE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 16. GLOBAL CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 17. GLOBAL METAGENOMICS MARKET BY APPLICATION, 2018 & 2027 (%)

FIGURE 18. GLOBAL CLINICAL DIAGNOSTIC MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 19. GLOBAL DRUG DISCOVERY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 20. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 21. NORTH AMERICA METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)

FIGURE 22. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 23. NORTH AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)

FIGURE 24. US METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 25. CANADA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 26. MEXICO METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 27. EUROPE METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)

FIGURE 28. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 29. EUROPE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)

FIGURE 30. UK METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 31. GERMANY METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 32. FRANCE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 33. ASIA PACIFIC METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)

FIGURE 34. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 35. ASIA PACIFIC METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)

FIGURE 36. CHINA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 37. JAPAN METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 38. INDIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 39. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)

FIGURE 40. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 41. MIDDLE EAST AND AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)

FIGURE 42. UAE METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 43. SAUDI ARABIA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 44. SOUTH AFRICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 45. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE, BY COUNTRY, 2018 (US$ MN)

FIGURE 46. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 47. SOUTH AND CENTRAL AMERICA METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)

FIGURE 48. BRAZIL METAGENOMICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

FIGURE 49. GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018

FIGURE 50. ORGANIC GROWTH STRATEGIES IN THE METAGENOMICS MARKET, 2015-2018

FIGURE 51. INORGANIC DEVELOPMENTS IN THE METAGENOMICS MARKET, 2015-2018

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370